Prostate cancer trials in China

In China 252 Also abroad 1481

252 trials · From ClinicalTrials.gov, checked 12 November 2026. Ask the study team whether a trial fits you.

No phaseNot yet taking people in China
Enhanced Recovery After Surgery (ERAS) Pathway in Patients Undergoing Robot-Assisted Laparoscopic Radical Prostatectomy
Where
Beijing
Age
60 years to 90 years
People
54
Run by
Peking University First Hospital
See details and how to joinNCT05576766
No phaseTaking people
Comprehensive Versus Primary Tumor Radiotherapy in Oligometastatic Prostate Cancer
Where
Beijing
Age
18 years to 85 years
People
390
Run by
Peking University First Hospital
See details and how to joinNCT07015138
No phaseEnrolling by invitation
Clinical Study of Rezvilutamide Combined With Docetaxel Chemotherapy in the Treatment of Abiraterone-Resistant Prostate Cancer
Where
Guangzhou
Age
18 years and over
People
20
Run by
Zhujiang Hospital
See details and how to joinNCT07112209
Phase 1/2Not yet taking people in China
Study of TY-302 Capsules Combined With Abiraterone in Patients With Metastatic Castration-resistant Prostate Cancer（mCRPC）
Where
Hangzhou
Age
18 years and over
People
48
Run by
TYK Medicines, Inc
See details and how to joinNCT07104617
Phase 1/2Not yet taking people in China
Study of TYK-00540 Combined With Enzalutamide in Patients With Metastatic Castration-resistant Prostate Cancer（mCRPC）
Where
Hangzhou
Age
18 years and over
People
48
Run by
TYK Medicines, Inc
See details and how to joinNCT07104643
Phase 1Taking people
A Study of [177Lu] Lu-PSMA-XT Injection in Patients With Metastatic Prostate Cancer
Where
Beijing
Age
18 years and over
People
36
Run by
Jinming Zhang
See details and how to joinNCT07096128
Phase 1Taking people
Study of SYN818 for the Treatment of Advanced or Metastatic Solid Tumors
Where
Shanghai, Zhengzhou
Age
18 years and over
People
30
Run by
Hangzhou SynRx Therapeutics Biomedical Technology Co., Ltd
See details and how to joinNCT06666270
Phase 1/2Not yet taking people in China
Phase I/II Clinical Study of HRS-1738 for the Diagnosis of Prostate Cancer Patients
Where
Beijing
Age
18 years and over
People
50
Run by
Jiangsu HengRui Medicine Co., Ltd.
See details and how to joinNCT07056439
Phase 1/2Taking people
Research on the Application of 68Ga-PSMA-CYC PET Imaging in the Diagnosis, Staging, and Restaging of Prostate Cancer
Where
Fuzhou
Age
18 years to 80 years
People
40
Run by
First Affiliated Hospital of Fujian Medical University
See details and how to joinNCT07056790
No phaseTaking people
Comparison of MRI Artificial Intelligence-guided cTB Versus Routine cTB in Prostate Cancer Diagnosis
Where
Beijing
Age
45 years to 85 years
People
360
Run by
Peking University First Hospital
See details and how to joinNCT06392737
Phase 1Taking people
HS-10502 Combination Treatment in Patients With Advanced Solid Tumors
Where
Shanghai
Age
18 years and over
People
157
Run by
Jiangsu Hansoh Pharmaceutical Co., Ltd.
See details and how to joinNCT06769425
Phase 2Not yet taking people in China
Study of ZG006 in Participants With Neuroendocrine Prostate Cancer
Where
Shanghai
Age
18 years to 80 years
People
60
Run by
Suzhou Zelgen Biopharmaceuticals Co.,Ltd
See details and how to joinNCT07024277
No phaseTaking people
Evaluation of Targeted Biopsy Plus Sextant Biopsy in Diagnosis of Prostate Cancer
Where
Beijing
Age
45 years to 85 years
People
300
Run by
Peking University First Hospital
See details and how to joinNCT06684652
Phase 1Taking people
Phase I Study of HSK46575 in Patients With Metastatic Castration-Resistant Prostate Cancer
Where
Chengdu
Age
18 years and over
People
90
Run by
Haisco Pharmaceutical Group Co., Ltd.
See details and how to joinNCT07007910
No phaseTaking people
Novel Therapy Target in Metastatic Prostate Cancer
Where
Shanghai
Age
18 years and over
People
100
Run by
Fudan University
See details and how to joinNCT05577689
Phase 1Taking people
A Study of Hansoh (HS)-10502 in Patients With Advanced Solid Tumors
Where
Beijing
Age
18 years to 75 years
People
318
Run by
Jiangsu Hansoh Pharmaceutical Co., Ltd.
See details and how to joinNCT05740956
Early phase 1Taking people
99mTc-QULIC-5-P1 SPECT Imaging in Patients With Prostate Cancer
Where
Chongqing
Age
18 years and over
People
30
Run by
First Affiliated Hospital of Chongqing Medical University
See details and how to joinNCT06419348
Phase 2Taking people
Radiotherapy or Surgery Combined With Intense Androgen Deprivation Therapy for mCRPC
Where
Nanjing
Age
18 years to 80 years
People
144
Run by
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
See details and how to joinNCT06992232
No phaseTaking people
Improved Robotic-Assisted Radical Prostatectomy for Locally Advanced Prostate Cancer: Bladder Suspension and Preliminary Outcomes
Where
Fuzhou
People
300
Run by
First Affiliated Hospital of Fujian Medical University
See details and how to joinNCT06977906
Phase 2/3Taking people
Maximal Tumor Eradication for Oligometastatic Prostate Cancer
Where
Shanghai
Age
18 years to 75 years
People
120
Run by
RenJi Hospital
See details and how to joinNCT06972511
Phase 2Taking people
Radiotherapy Combined With Fluzopanib and Abiraterone Acetate Tablets (II) Treatment for mCRPC
Where
Shenyang
Age
18 years and over
People
40
Run by
Jianbin Bi
See details and how to joinNCT06971211
No phaseTaking people
Exploring the Correlation Between MRI Image Characteristics and Diagnosis, Pathology and Prognosis in Patients With Prostate Lesions
Where
Wuhan
Age
18 years and over
People
500
Run by
Zhen Li
See details and how to joinNCT06946771
No phaseTaking people
Prospective Evaluation of Cornerstone Robotics Sentire Surgical System in Major Gastrointestinal and Urologic Surgery
Where
Hong Kong
Age
18 years to 80 years
People
90
Run by
Chinese University of Hong Kong
See details and how to joinNCT06926374
Phase 3Not yet taking people in China
Phase III Clinical Trial to Evaluate INR101 Injection for PET/CT Imaging in Patients With Prostate Cancer.
Where
Beijing, Cangzhou, Changsha, Hangzhou, Nanjing, Shanghai, Suzhou, Taizhou, Tianjin, Wuhan, Yichang
Age
18 years and over
People
240
Run by
Yunhe Pharmaceutical (Tianjin) Co., Ltd
See details and how to joinNCT06922903
Phase 3Not yet taking people in China
A Multicenter, Open-label, Prospective Phase III Clinical Trial to Evaluate INR101 Injection for PET/CT Imaging in Participants With Suspected Recurrent Prostate Cancer After Radical Treatment
Where
Beijing, Cangzhou, Changsha, Hangzhou, Nanjing, Shanghai, Suzhou, Taizhou, Tianjin, Wuhan, Yichang
Age
18 years and over
People
110
Run by
Yunhe Pharmaceutical (Tianjin) Co., Ltd
See details and how to joinNCT06922929